External Advisory Board

  • Head of the board: Michael E. STERN, Chief Scientific Officer of ImmunEyez
  • Jean-Marie STASSEN, Head of R&D at Amakem
  • Virginia CALDER, Faculty of Brain Sciences, University College of London
  • Christel MENET, CSO at Confo Therapeutics
  • Carina KOPPEN, MD Head Ophthalmology, University Hospital Antwerp (UZA)

Coordinator Office

  • Koen AUGUSTYNS, Coordinator, University of Antwerp (UA)
  • María J. GONZÁLEZ-GARCÍA, Director of Training, University of Valladolid (UVA)
  • Maya BERG, Supervisor of Coordination and Scientific Research Manager, University of Antwerp (UA)
  • Paz YANEZ, Project Manager, University of Antwerp (UA)

Supervisory Board

  • Koen AUGUSTYNS, University of Antwerp (UA)
  • Paul COS, University of Antwerp (UA)
  • Antoine LABBE, Sorbonne Université (SU)
  • Amalia ENRÍQUEZ-DE-SALAMANCA, University of Valladolid (UVA)
  • Aigars JIRGENSONS, Latvian Institute of Organic Synthesis (LIOS)
  • Marika RUPONEN, University of Eastern Finland (UEF)
  • Philipp STEVEN, University Hospital of Cologne (UHC)
  • Maria RÓSARIO BRONZE, The Institute of Experimental Biology and Technology (iBET)
  • Peter MOLENVELD, Mercachem BV
  • Carmen ALVAREZ-LORENZO, HGBeyond Materials Science S.L.D
  • Markus BEIER, Novaliq GmbH
  • Antoine LABBÉ, Centre Hospitalier Nationale des Quinze-Vingts
  • Carole GARD, Horus Pharma
  • Ali TAFRESHI, Heidelberg Engineering

Dissemination & Exploitation Board

  • Koen AUGUSTYNS, University of Antwerp (UA)
  • Jurgen JOOSSENS, Head of the Valorisation Office at University of Antwerp (UA) and Exploitation Committee Manager of the Board
  • Antoine LABBÉ, Sorbonne Université (SU)
  • Romain GOUMENT, Head of programs and partnerships chez Institut de la Vision, Sorbonne Université (SU)
  • María J. GONZÁLEZ-GARCÍA, University of Valladolid (UVA)
  • Yolanda CALVO, Innovation Department Manager at University of Valladolid (UVA)
  • Aigars JIRGENSONS, Latvian Institute of Organic Synthesis (LIOS)
  • Dace KARKLE, Deputy Director of Administration, Finance and Law at Latvian Institute of Organic Synthesis (LIOS)
  • Arto URTTI, University of Eastern Finland (UEF)
  • Matti HÖYTÖ, Business Development Advisor at University of Eastern Finland (UEF)
  • Philipp STEVEN, University Hospital of Cologne (UHC)
  • Petra SCHREINER-KAUB, EU and International Projects Management at University Hospital of Cologne (UHC)
  • Maria RÓSARIO BRONZE, The Institute of Experimental Biology and Technology (iBET)